US Stock MarketDetailed Quotes
NNVC Nanoviricides
- 1.340
- +0.060+4.69%
Close Nov 22 16:00 ET
- 1.310
- -0.030-2.24%
Post 20:01 ET
19.22MMarket Cap-1763P/E (TTM)
1.370High1.250Low133.74KVolume1.270Open1.280Pre Close177.61KTurnover0.97%Turnover RatioLossP/E (Static)14.35MShares3.59052wk High1.90P/B18.46MFloat Cap1.00052wk Low--Dividend TTM13.78MShs Float262.500Historical High--Div YieldTTM9.38%Amplitude1.000Historical Low1.327Avg Price1Lot Size
About Nanoviricides Company
NanoViricides, Inc. is a clinical stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.
Company Profile
SymbolNNVC
Company NameNanoviricides
Listing DateSep 25, 2013
Founded2005
CEODr. Anil R. Diwan, PhD
MarketAMEX
Employees7
Fiscal Year Ends06-30
Address1 Controls Drive
CityShelton
ProvinceConnecticut
CountryUnited States of America
Zip Code06484
Phone1-203-937-6137
Websitehttp://www.nanoviricides.com
Company Executives
- Name
- Position
- Salary
- Meeta Vyas, M.B.A.,S.B.
- Chief Financial Officer and Principal Accounting Officer
- 135.51K
- Dr. Anil R. Diwan, PhD
- Executive Chairman of the Board, President and Principal Executive Officer
- 432.50K
- Brian Zucker, C.P.A.
- Independent Director
- 40.00K
- Theodore Edward Rokita, Esq.
- Independent Director
- 40.00K
- Dr. Makarand Jawadekar, PhD
- Independent Director
- 40.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data